Title: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
Announcement Number: RFA-OD-20-003Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R61/R33
Title: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
Announcement Number: RFA-OD-20-004Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R21
Title: Clinical Trials Development for Co-Occurring Conditions in Individuals with Down syndrome: Phased Awards for INCLUDE (R61/R33 Clinical Trial Required)
Announcement Number: RFA-OD-20-003Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R61/R33
Title: INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE (INCLUDE) Clinical Trial Readiness (R21 Clinical Trial Not Allowed)
Announcement Number: RFA-OD-20-004Release Date: Friday, December 13, 2019
Expiration Date: Thursday, November 4, 2021
Activity Code: R21
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)
Announcement Number: RFA-NS-20-010Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-011Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-011Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R43/R44
Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)
Announcement Number: RFA-NS-20-008Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R41/R42
Title: HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)
Announcement Number: RFA-NS-20-009Release Date: Friday, October 4, 2019
Expiration Date: Friday, September 9, 2022
Activity Code: R41/R42
Title: The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)
Announcement Number: RFA-OD-19-029Release Date: Friday, September 27, 2019
Expiration Date: Saturday, November 27, 2021
Activity Code: R01
Title: HEAL Initiative: Translational Devices to Treat Pain (UG3/UH3 Clinical Trial Optional)
Announcement Number: RFA-NS-19-016Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: UG3/UH3
Title: HEAL Initiative: Translational Devices to Treat Pain (U44 Clinical Trial Optional)
Announcement Number: RFA-NS-19-017Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: U44
Title: HEAL Initiative: Clinical Devices to Treat Pain (UH3 Clinical Trial Optional)
Announcement Number: RFA-NS-19-018Release Date: Monday, December 10, 2018
Expiration Date: Tuesday, February 23, 2021
Activity Code: UH3